News Article | May 16, 2017
BROOKLYN, NY, May 16, 2017-- Sarah Mook is a celebrated Marquis Who's Who biographee. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.Marquis Who's Who, the world's premier publisher of biographical profiles, is proud to name Ms. Mook a Lifetime Achiever. An accomplished listee, Ms. Mook celebrates many years' experience in her professional network, and has been noted for achievements, leadership qualities, and the credentials and successes she has accrued in her field.Before her retirement, Ms. Mook worked as the principal chemist at the Bellevue Hospital Center.In addition to her status as a Lifetime Achiever, Ms. Mook was named Woman of the Year by the New York City Council, and received a Certificate of Recognition from the Community Advisory Board of the Coney Island Hospital and the Marjorie Matthews Community Advocate Recognition Award from New York City Health and Hospitals Corporation. She also received a Distinguished Leadership in Community Award from the New York City Office of Comptroller, the Woman of the Year Humanitarian Award from the New York State Senate and the Margaret M. McCord Woman of Year Memorial Award from the Sheepshead Bay-Brooklyn Historical Society. Ms. Mook has also been featured in a plethora of Marquis publications over the years, including Who's Who in America, Who's Who in Science and Engineering, Who's Who in the East, Who's Who in the World and Who's Who of American Women.About Marquis Who's Who :Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America , Marquis Who's Who has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Today, Who's Who in America remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis publications may be visited at the official Marquis Who's Who website at www.marquiswhoswho.com Contact:Fred Marks844-394-6946
News Article | December 8, 2016
LYON, France & NEW YORK--(BUSINESS WIRE)--The MEDICREA Group (Alternext Paris: FR0004178572 - ALMED), worldwide leader pioneering the development and manufacture of personalized analytical services and implant solutions for the treatment of complex spinal conditions, today announced that it will host a Key Opinion Leader breakfast in New York City for investors focused on advances in the personalized spine market at 8:00 am Eastern Time on Thursday, December 15, 2016. The meeting will feature keynote presentations by spine surgeon KOLs Nicholas Qandah, DO, from the Mohawk Valley Health System, and Themistocles Protopsaltis, MD, from NYU Langone Medical Center, Bellevue Hospital, who will provide an overview of the complex spine market and discuss current and novel approaches to treating complex spinal conditions. Members of the Medicrea management team will provide an overview of the Company’s UNiD™ personalized spinal technology platform of analytical services and patient-specific implants for the complex spine market, which received the first ever FDA Clearance for a personalized spinal treatment modality. Dr. Nicholas Qandah is a complex spine specialist and the Director of Neurosurgery at the Mohawk Valley Health System in New Hartford, NY. Dr. Qandah was previously the Director of the Complex Spine Program for Neurosurgery and an Assistant Professor of Neurosurgery for the Residency Program at Virginia Tech Carilion Clinic in Roanoke, VA. In addition to general neurosurgery, Dr. Qandah treats patients with back and neck pain, degenerative disc disease, spinal stenosis, and herniated discs. He has special interest and expertise in minimally invasive spine surgery, complex spine surgery, and surgery for scoliosis. Dr. Qandah is a Fellow of the American College of Osteopathic Surgeons and a member of the Association for Collaborative Spine Research. Dr. Qandah completed his Neurosurgical Residency training at the Virginia Tech Carilion Clinic and was subsequently awarded the AO Complex Spine Fellowship in Orthopedics and Neurosurgery at the prestigious Harborview Medical Center at the University of Washington in Seattle, WA. Dr. Themistocles Protopsaltis is an orthopedic spine surgeon at NYU Langone Medical Center and the Hospital for Joint Diseases. He serves as Director of Adult Spinal Deformity Surgery and Director of the Orthopaedic Spine Service at Bellevue Hospital Center in New York, NY. He is also an Assistant Professor in the Department of Orthopedic Surgery at NYU School of Medicine. Dr. Protopsaltis is board certified in orthopedic surgery and is actively involved in many research areas. Some of his interests include cervical and thoracolumbar spinal deformity, cervical spondylotic myelopathy surgical outcomes, and proximal junctional kyphosis avoidance in adult scoliosis patients. He is a member of the International Spine Study Group, comprised of leading physicians from multiple academic centers studying cervical and thoracolumbar spinal deformity surgery. He is also a fellow of the American Academy of Orthopaedic Surgeons. Dr. Protopsaltis earned his medical degree at the Columbia University College of Physicians and Surgeons and completed his orthopedic surgery residency at New York Presbyterian Hospital. He has completed a spine surgery fellowship at NYU Langone Hospital for Joint Diseases. The event is intended for investors, analysts, investment bankers, and business development professionals only. If you would like to attend in person, please contact Mac MacDonald at 212-915-2567 or via e-mail at Mac@LifeSciAdvisors.com to reserve a place. A live webcast of the event, with slides, will be available at http://lifesci.rampard.com/20161215/reg.jsp and within the Investors section of the Company’s website at www.medicrea.com. MEDICREA specializes in bringing pre-operative digital planning and pre and post-operative analytical services to the world of complex spine. Through the lens of predictive medicine, MEDICREA leads the design, integrated manufacture, and distribution of 30+ FDA approved implant technologies, utilized in over 100k spinal surgeries to date. Operating in a $10 billion marketplace, MEDICREA is an SME with 150 employees worldwide, which includes 55 at its USA Corp. subsidiary in NYC. The Company has an ultra-modern manufacturing facility in Lyon, France housing the development and production of 3D-printed titanium patient- specific implants. By leveraging its proprietary software analysis tools with big data and deep learning technologies supported by an expansive collection of clinical and scientific data, MEDICREA is well-placed to streamline the efficiency of spinal care, reducing procedural complications and limiting time spent in the O.R. For further information, please visit: medicrea.com.
News Article | October 28, 2016
With an upcoming publication in the Worldwide Leaders in Healthcare, Andrew Wuthrich, MSN, RN, ONC, NE-BC, joins the prestigious ranks of the International Nurses Association. He is a Registered Nurse with 10 years of experience in his field and an extensive expertise in all facets of nursing, especially nursing education, cardiothoracic intensive care nursing, retinal ambulatory surgery nursing, post-anesthesia care, acute care nursing, public health, traumatic brain injury nursing, step-down unit, and orthopedic nursing. Andrew is currently serving patients as Clinical Nurse Educator at NYU Langone Medical Center’s Hospital for Joint Diseases in New York City, New York. Furthermore, he is affiliated with Bellevue Hospital Center. A Nurse Executive-Board Certified, Andrew received his Associate degree in Nursing in 2006 from Rockland Community College, followed by his Bachelor of Science degree in Nursing in 2010 from Chamberlain College of Nursing in Downers Grove, Illinois. An advocate for continuing education, Andrew attended the Benedictine University in Lisle, Illinois, and obtained his Master of Science degree in Nursing with a focus on Nursing Administration in 2013. Additionally, he is an inductee of the Sigma Theta Tau International Honor Society of Nursing and Phi Sigma Omicron Academic Honor Society, and maintains professional memberships with the Association of Nursing Professional Development, and the National Association of Orthopaedic Nurses. Andrew is also the recipient of numerous awards and recognitions, including President’s Honors in 2010 at Chamberlain College of Nursing, Nursing Spectrum Finalist for Home Community & Ambulatory Care, Evidence Based Practice Award, Outstanding Student Service Award from 2004-2006, and was the Foundation Memorial Scholarship recipient from 2004-2005. Andrew started his experience in the healthcare arena as an Emergency Medical Technician for the United States Air Force. He then worked in a surgical intensive care unit with registered nurses who were his clinical leaders. He was impressed with their clinical knowledge, skills, and leadership capabilities. Andrew was drawn to the role and wanted to advance his education and develop those critical skills that will not just propel his career, but will cultivate lifelong skills in work and in life. He attributes his success to Dr. Althea L. Mighten, his current Director of Nursing Education. She has been a beacon of light in the role as a development practitioner. She embodies a heart and soul in her craft and expertly delivers high quality educational offerings for the institution. In addition, Andrew attributes his success to Dr. Ben Z. Cohen, an ophthalmologist and superb retina specialist, who is an excellent motivator, teacher, and mentor. He also attributes his success to the many professors of nursing and staff nurses, that he has learned from in his years of practice. When he is not working, he enjoys going to the beach, practicing Yoga, kickboxing, and hiking. Learn more about Andrew Wuthrich here: http://inanurse.org/network/index.php?do=/4133234/info/ and read his upcoming publication in the Worldwide Leaders in Healthcare.
News Article | November 3, 2016
"The goal of this novel faculty development program," explains Dr. Chinn, "is to recruit, develop, and retain faculty who are committed to teaching the delivery of quality, interprofessional, community-based oral health care for underserved pediatric, adolescent, and special needs populations and to inspire trainees to utilize their skills in their future careers." Grant partners of the NYU Department of Pediatric Dentistry include the NYU Dentistry Office of Allied Health Programs, Office of Professional Development, and Office of Student Affairs & Academic Support Services. Growing Success seeks to achieve this goal by establishing a community-based educator track for qualified pediatric dentists and dental hygienists who demonstrate sincere interest in teaching students to deliver successful community-based dental services. Over the five-year program, selected faculty will receive educational loan repayment and participate in structured development activities designed to bolster their personal professional portfolios while simultaneously building their confidence, comfort, and skill sets to succeed in educating future dental professionals. The program consists of a core "community-based curriculum" offered by NYU Dentistry's Office of Faculty Development; pre-selection into one of three "community-based concentrations" (in school-based oral health, interprofessional education, or community dental hygiene) offered by the College's Department of Pediatric Dentistry and its Office of Allied Health Programs; guided mentorship; and individually-tailored faculty development experiences. Growing Success leverages the extensive network of NYU Department of Pediatric Dentistry community partners including Head Start, the New York City Department of Education and Department of Health and Mental Hygiene, Bellevue Hospital Center, the NYU Meyers College of Nursing, and the NYU School of Medicine to place faculty and students in community-based primary care sites throughout New York City. Through these placements, Growing Success seeks to improve the effectiveness and efficiency of current community programs while strengthening existing partnerships. Moreover, as the largest dental school in the US, NYU Dentistry is uniquely positioned to help narrow the dental workforce gap for underserved pediatric populations not only in New York City but beyond, as faculty who complete this track go on to teach and practice across the nation. "The current challenge facing dental professionals and oral health advocates," says Dr. Chinn, "is to ensure an adequate and appropriately trained dental workforce that can successfully meet the oral health needs of a large and growing US pediatric population. The next generation of dentists and hygienists must be equipped with the knowledge, experience, and confidence that will allow them to successfully provide services and improve access to care for traditionally underserved communities. Recruiting and supporting diverse, high-quality dental school faculty is a crucial element in facilitating the growth and success of our future dental professionals." New York University College of Dentistry (NYU Dentistry) is the third oldest and the largest dental school in the US, educating 8 percent of all dentists. NYU Dentistry has a significant global reach and provides a level of national and international diversity among its students that is unmatched by any other dental school. Visit http://dental. for more.
Hendricks-Munoz K.D.,Virginia Commonwealth University |
Mayers R.M.,Bellevue Hospital Center
American journal of perinatology | Year: 2014
OBJECTIVE: This study assessed the impact of a nurse simulation training program on perception of kangaroo mother care (KMC) value and transfer skill competency.RESULTS: Nurses' competency in infant transfer improved, especially in infants receiving nasal continuous positive airway pressure or ventilator support, from 30 to 93% or 10 to 50%, respectively, p < 0.0001. Neonatal nurses' perceived KMC value increased from 50 to 100%, p < 0.001, and parent KMC utilization increased from 26.5 to 85.9%, p < 0.0001. Nurses' support for parental visitation improved from 38 to 73%, p < 0.001; discussion of KMC with parents on the 1st day increased from 5 to 45%, p < 0.001; and initial day of KMC provision improved from 18.0 ± 2.7 to 5.6 ± 1.2 days, p < 0.001.STUDY DESIGN: An 8-item Likert scale skill survey tool and a 24-item Likert developmental care survey tool were used in a prospective cohort study to analyze perceptions of 30 neonatal nurses who underwent a comprehensive KMC simulation-based training program. Competency skills were evaluated pretraining and tracked by direct observation for 6 months posttraining. Pre- and postsurvey data were analyzed and KMC utilization for preterm infants born at ≤ 34 weeks' gestation was determined.CONCLUSIONS: A comprehensive simulation-based KMC education program improved nurses' perception of KMC value, their competency and comfort in infant transfer for KMC care, and successfully promoted KMC parent utilization for the preterm infant in the neonatal intensive care unit. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
Ross S.,Bellevue Hospital Center |
Ross S.,New York University |
Peselow E.,New York University
Clinical Neuropharmacology | Year: 2012
Psychosis and substance abuse are intimately related. Psychotic spectrum illnesses commonly co-occur with substance use disorders (SUDs), and many substances of abuse can cause or exacerbate psychotic symptoms along a temporal spectrum from acute to chronic presentations. Despite the common co-occurrence between psychotic spectrum illnesses and SUDs, they are often under-recognized and undertreated, leading to poor treatment outcomes. Accurate detection and diagnosis of individuals with psychotic illness co-occurring with addictive disorders is key to properly treat such disorders. This article will review the nature of the relationship between psychosis and substance abuse by examining prevalence rates of each disorder alone and their rates of co-occurrence, the neurobiological basis for substance abuse comorbidity in schizophrenia spectrum disorders, key and salient aspects related to accurate diagnosis along a continuum from acute to subacute to chronic conditions, and pitfalls associated with diagnostic dilemmas. A case example will be used to highlight key points related to diagnostic challenges Copyright © 2012 by Lippincott Williams & Wilkins.
Parikh M.,New York University |
Parikh M.,Bellevue Hospital Center |
Issa R.,New York University |
Issa R.,Bellevue Hospital Center |
And 7 more authors.
Annals of Surgery | Year: 2013
OBJECTIVE: To conduct a systematic review to identify surgical strategies that may decrease leak after laparoscopic sleeve gastrectomy (LSG). BACKGROUND: LSG is growing in popularity as a primary bariatric procedure. Technical aspects of LSG including bougie size remain controversial. METHODS: Our systematic review yielded 112 studies encompassing 9991 LSG patients. A general estimating equation (GEE) model was used to calculate the odds ratio (OR) for leak based on bougie size, distance from the pylorus, and use of buttressing on the staple line. Baseline characteristics, including age and body mass index (BMI), were included. A linear repeated measures regression model compared excess weight loss (%EWL) between bougie sizes. RESULTS: A total of 198 leaks in 8922 patients (2.2%) were identified. The GEE model revealed that the risk of leak decreased with bougie ≥40 Fr (OR = 0.53, 95% CI = [0.37-0.77]; P = 0.0009). Buttressing did not impact leak. There was no difference in %EWL between bougie <40 Fr and bougie ≥40 Fr up to 36 months (mean: 70.1% EWL; P = 0.273). Distance from the pylorus did not affect leak or %EWL. CONCLUSIONS: Utilizing bougie ≥40 Fr may decrease leak without impacting %EWL up to 3 years. Distance from the pylorus does not impact leak or weight loss. Buttressing does not seem to impact leak; however, if surgeons desire to buttress, bioabsorbable material is the most common type used. Longer-term studies are needed to definitively determine the effect of bougie size on weight loss after LSG. Copyright © 2013 by Lippincott Williams & Wilkins.
Smith S.W.,New York University |
Smith S.W.,New York City Poison Control Center |
Smith S.W.,Bellevue Hospital Center
Journal of Medical Toxicology | Year: 2013
These proceedings will review the role of chelation in five metals-aluminum, cadmium, chromium, cobalt, and uranium-in order to illustrate various chelation concepts. The process of "chelation" can often be oversimplified, leading to incorrect assumptions and risking patient harm. For chelation to be effective, two critical assumptions must be fulfilled: the presumed "metal toxicity" must correlate with a given body or a particular compartment burden, and reducing this compartmental or the body burden (through chelation) attenuates toxicity. Fulfilling these assumptions requires an established dose-response relationship, a validated, reproducible means of toxicity assessment (clinical, biochemical, or radiographical), and an appropriate assessment mechanisms of body or compartment burden. While a metal might "technically" be capable of chelation (and readily demonstrable in urine or feces), this is an insufficient endpoint. Clinical relevance must be affirmed. Deferoxamine is an accepted chelator for appropriately documented aluminum toxicity. There is a very minimal treatment window in order to address chelation in cadmium toxicity. In acute toxicity, while no definitive chelation benefit is described, succimer (DMSA), diethylenetriaminepentaacetate (DTPA), and potentially ethylenediaminetetraacetic acid (EDTA) have been considered. In chronic toxicity, chelation is unsupported. There is little evidence to suggest that currently available chromium chelators are efficacious. Similarly, scant human evidence exists with which to provide recommendation for cobalt chelation. DTPA has been recommended for cobalt radionuclide chelation, although DMSA, EDTA, and N-acetylcysteine have also been suggested. DTPA is unsupported for uranium chelation. Sodium bicarbonate is currently recommended, although animal evidence is conflicting. © 2013 American College of Medical Toxicology.
Jacko S.,Bellevue Hospital Center
Journal of trauma nursing : the official journal of the Society of Trauma Nurses | Year: 2012
Blunt pancreatic trauma is rare; however, if missed, it can lead to devastating consequences such as fistula, pancreatitis, and pseudocyst. Blunt trauma accounts for 30% of all pancreatic injuries. High-speed motor vehicle collisions make up the greatest proportion of blunt pancreatic trauma, whereas other causes could be easily overlooked because of being so rare. In this case report we present a case of full-thickness transection of pancreatic tail after being kicked by a horse. The injury was timely identified and successfully treated by completing transection with a stapler. Considering that delay in diagnosis leads to a morbidity rate of 20%, physicians must have high level of suspicion and knowledge of invasive and noninvasive modalities to ensure early detection of pancreatic trauma and a positive outcome.
Odedosu T.,Bellevue Hospital Center |
Schoenthaler A.,New York University |
Vieira D.L.,NYU Langone Medical Center |
Agyemang C.,Amsterdam Medical Center |
Ogedegbe G.,New York University
Cleveland Clinic Journal of Medicine | Year: 2012
Barriers to blood pressure control exist at the patient, physician, and system levels. We review the current evidence for interventions that target patient- and physician-related barriers, such as patient education, home blood pressure monitoring, and computerized decisionsupport systems for physicians, and we emphasize the need for more studies that address the effectiveness of these interventions in African American patients.